At the same time, SHMT2 can significantly affect the overall survival and disease-free survival time of BLCA patients, and change the proliferation and apoptosis levels of BLCA cells (Zhang and Yang, 2021). Here, SHMT2 is linked to bladder transitional cell carcinoma.